Schrödinger

Schrödinger is a company that leverages physics-based computational platforms for molecular discovery and design, offering solutions for both small molecule and biologics discovery across various industries.

Services

Schrödinger provides a comprehensive suite of solutions for small molecule and biologics discovery. Key services include structure prediction, target enablement, hit discovery, hit-to-lead, lead optimization, and drug formulation. For biologics discovery, Schrödinger's platform supports antibody design, peptide discovery, and enzyme engineering. The company's services cater to various sectors, utilizing a combination of physics-based molecular modeling and machine learning.

Products

Schrödinger's critical products include Maestro, LiveDesign, FEP+, BioLuminate, and Modeling Services. Maestro is used for molecular visualization and analysis, while LiveDesign focuses on collaborative molecular design. FEP+ offers free energy perturbation for accurate binding affinity predictions. BioLuminate serves biologics researchers, and Modeling Services provide custom computational modeling support. Schrödinger's products integrate seamlessly to support molecular discovery and design workflows.

Sector

Schrödinger's computational platform supports a broad range of industries. These include academic research, biotechnology, pharmaceuticals, consumer packaged goods, oil and gas, and specialty chemicals. The platform's versatility enables applications in both therapeutic discovery and material design, leveraging advanced computational technologies to meet diverse industry needs.

Clinical Programs

Schrödinger has a proprietary pipeline with several clinical programs. Notable among these are SGR-1505, a MALT1 inhibitor in Phase 1 clinical development for treating relapsed or refractory B-cell lymphomas, and SGR-2921, a CDC7 inhibitor also in Phase 1 development, aimed at treating acute myeloid leukemia or myelodysplastic syndromes. These programs demonstrate Schrödinger's commitment to advancing novel therapeutic candidates.

Global Presence and Recognition

Schrödinger has a significant global presence, employing over 800 professionals across more than a dozen offices worldwide. The company has earned accolades such as inclusion in America's 100 Most Loved Workplaces and recognition as one of the Best-Led Companies. Schrödinger's efforts to enhance human health and quality of life through innovative molecular discovery reflect its prestigious standing in the industry.

Companies similar to Schrödinger